Challenges in therapy of chronic hepatitis B.
Hoofnagle
Jay H
JH
Division of Digestive Diseases and Nutrition, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Room 9A27, Building 31, 31 Center Drive, Bethesda, MD 20892, USA. hoofnaglej@extra.niddk.nih.gov
D000998:Antiviral Agents / Q000627:therapeutic use*; D002353:Carrier State; D002986:Clinical Trials as Topic; D004279:DNA, Viral / Q000032:analysis; D006513:Hepatitis B e Antigens / Q000032:analysis; D006515:Hepatitis B virus / Q000187:drug effects / Q000235:genetics; D019694:Hepatitis B, Chronic / Q000175:diagnosis / Q000188:drug therapy* / Q000276:immunology; D006801:Humans; D016896:Treatment Outcome
D000998:Antiviral Agents; D004279:DNA, Viral; D006513:Hepatitis B e Antigens